Entry Detail



General Information

Database ID:exR0350298
RNA Name:hsa-miR-424-5p
RNA Type:miRNA
Chromosome:chrX
Starnd:-
Coordinate:
Start Site(bp):134546680End Site(bp):134546701
External Links:hsa-miR-424-5p



Disease Information

Disease Name:Hepatocellular Carcinoma
Disease Category:Cancers
MeSH ID:D006528
Type:Neoplasms/Digestive System Neoplasms
Alias:Carcinoma, Hepatocellular//Carcinomas, Hepatocellular//Hepatocellular Carcinomas//Liver Cell Carcinoma, Adult//Liver Cancer, Adult//Adult Liver Cancer//Adult Liver Cancers//Cancer, Adult Liver//Cancers, Adult Liver//Liver Cancers, Adult//Liver Cell Carcinoma//Carcinoma, Liver Cell//Carcinomas, Liver Cell//Cell Carcinoma, Liver//Cell Carcinomas, Liver//Liver Cell Carcinomas//Hepatocellular Carcinoma//Hepatoma//Hepatomas



Expression Detail

GEO ID:GSE85679
Description:Serum miRNA in liver disease
Experimental Design:Surgery treatment
Case Disease Type:Hepatocellular Carcinoma
Case Disease SubType:NA
Case Sample:Hepatocellular Carcinoma Post surgery 4
Control Sample:Pre surgery
Number of Case:98
Number of Control:98
Number of Samples:196





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AADAT
chr4
170060222
170091699
-
ARRDC4
chr15
97960703
97973833
+
ASB1
chr2
238426742
238452250
+
ATXN2L
chr16
28823035
28837237
+
BACE1
chr11
117285207
117316259
-
CASZ1
chr1
10636604
10796650
-
DCAF7
chr17
63550477
63594279
+
FAM102B
chr1
108560089
108644900
+
FLOT2
chr17
28879335
28897733
-
JADE2
chr5
134524312
134583230
+
KDSR
chr18
63327726
63367228
-
LITAF
chr16
11547722
11636381
-
LY6E
chr8
143017982
143023832
+
MAPKBP1
chr15
41774434
41827855
+
MED11
chr17
4731428
4733607
+
MINDY2
chr15
58771192
58861900
+
MRPS2
chr9
135499984
135504673
+
MYB
chr6
135181308
135219173
+
PRKAA1
chr5
40759379
40798374
-
RAPGEF1
chr9
131576770
131740074
-
RET
chr10
43077064
43130351
+
RTL8B
chrX
135020513
135022542
-
STEAP3
chr2
119223831
119265652
+
TOB2
chr22
41433494
41446801
-
ZNF664
chr12
123971845
124015439
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000458
chr12
124071293
124074996
+
hsa_circ_0001699
chr7
40027197
40041630
+
hsa_circ_0001387
chr4
1902352
1936989
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0000552
chr14
71880664
71948928
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0000652
chr15
90984737
90986710
+
hsa_circ_0001472
chr5
36953719
36976504
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
hsa_circ_0001164
chr20
45891031
45923523
-
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
NUTM2A-AS1
chr10
87201647
87342612
-
LINC02035
chr3
122886941
122892416
+
AC002470.2
chr22
20979462
20998121
+
AC021092.1
chr19
44103007
44113183
-
MCM3AP-AS1
chr21
46229196
46259390
+
LINC00662
chr19
27681072
27794005
-
MIR503HG
chrX
134543119
134546642
-
MIR497HG
chr17
7015818
7019659
-
AC079781.5
chr7
97851688
97972985
-
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
SNHG12
chr1
28578538
28583132
-
AC009022.1
chr16
69976297
70065948
-
LINC00649
chr21
33915534
33977691
+
AP000317.2
chr21
34073592
34360033
+
AL359924.1
chr1
237862175
237928321
+
AC114980.1
chr5
93860669
93863825
-
FGD5-AS1
chr3
14920347
14948424
-
AL031282.2
chr1
1702736
1737688
-
NUTM2B-AS1
chr10
79661394
79826594
-
AL391244.1
chr1
1420245
1422691
+
LINC01184
chr5
127939152
128083172
-
XIST
chrX
73820649
73852723
-
HCG18
chr6
30286690
30327382
-
SNHG16
chr17
76557764
76565348
+
SNHG25
chr17
64145970
64146476
+
SNHG1
chr11
62851984
62855953
-
AC020978.7
chr16
68224713
68227734
+
MZF1-AS1
chr19
58559129
58574797
+
MIR29B2CHG
chr1
207801518
207879115
-
AC003092.1
chr7
94022833
94066661
+
Display:



Experiment Detail

GEO ID:GSE85679
Sample Source:Blood
Source Fraction:Serum
Platform:GPL18941
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2524
Sample treatment protocol:NA
RNA Extract protocol:RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan).
RNA library preparation protocol:Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA